Factors involved in changes in hepatic lipogenesis during development of the rat.
1. Changes in the activities of acetyl-CoA carboxylase (EC 6.4.1.2), phosphofructokinase (EC 2.7.1.11), aldolase (EC 4.1.2.13), extramitochondrial aconitate hydratase (EC 4.2.1.3) and NADP-dependent isocitrate dehydrogenase (EC 1.1.1.42) have been measured in the livers of developing rats from late foetal life to maturity. 2. The effect of altering the weaning time on some enzymes associated with lipogenesis has been studied. Weaning rats at 15 days of age instead of 21 days results in an immediate increase in the activity of ;malic' enzyme (EC 1.1.1.40) whereas the activities of glucose 6-phosphate dehydrogenase (EC 1.1.1.49) and ATP citrate lyase (EC 4.1.3.8) did not increase until 4-5 days and acetyl-CoA carboxylase 2-3 days after early weaning. Weaning rats on to an artificial-milk diet led to complete repression of the rise in activity of hepatic enzymes associated with lipogenesis normally found on weaning, except for ;malic' enzyme, which increased in activity after 20 days of age. 3. The effect of intraperitoneal injections of glucagon, cortisol, growth hormone and thyroxine on the same hepatic enzymes has been investigated. Only thyroxine had any effect on enzyme activities and caused a 20-fold increase in ;malic' enzyme activity and a twofold increase in ATP citrate lyase activity. 4. The activities of hepatic glucose 6-phosphate dehydrogenase and ;malic' enzyme are higher in adult female than in adult male rats and it has been shown that this sex difference in enzyme activities is due to both male and female sex hormones. 5. Hepatic malate, citrate, pyruvate, glucose 6-phosphate and phosphoenolpyruvate concentrations have been measured throughout development. 6. The results are discussed in relation to the dietary and hormonal control of hepatic enzyme activities during development.
D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism; D002369:Castration; D002951:Citrates / Q000032:analysis; D004032:Diet; D005260:Female; D005333:Fetus / Q000378:metabolism; D005634:Fructose-Bisphosphate Aldolase / Q000032:analysis; D005934:Glucagon / Q000494:pharmacology; D005954:Glucosephosphate Dehydrogenase / Q000032:analysis; D013006:Growth Hormone / Q000494:pharmacology; D006836:Hydro-Lyases / Q000032:analysis; D006854:Hydrocortisone / Q000494:pharmacology; D007521:Isocitrate Dehydrogenase / Q000032:analysis; D008025:Ligases / Q000032:analysis; D008055:Lipids / Q000096:biosynthesis*; D008099:Liver / Q000201:enzymology / Q000254:growth & development* / Q000378:metabolism; D008190:Lyases / Q000032:analysis; D008291:Malate Dehydrogenase / Q000032:analysis; D008293:Malates / Q000032:analysis; D008297:Male; D010732:Phosphofructokinase-1 / Q000032:analysis; D011247:Pregnancy; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D012737:Sex Factors; D013974:Thyroxine / Q000494:pharmacology
D002951:Citrates; D008055:Lipids; D008293:Malates; D011773:Pyruvates; D013006:Growth Hormone; D005934:Glucagon; D008291:Malate Dehydrogenase; D007521:Isocitrate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D010732:Phosphofructokinase-1; D008190:Lyases; D005634:Fructose-Bisphosphate Aldolase; D006836:Hydro-Lyases; D008025:Ligases; D013974:Thyroxine; D006854:Hydrocortisone